ArticlePerioperative medicine (London, England)2025
Effect of (short-term) intravenous iron supplementation in iron-deficient non-anaemic cardiac surgical patients on perioperative outcome.
Article in Perioperative medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on "Association between non-anemic iron deficiency and outcomes following off-pump coronary artery bypass surgery: a retrospective analysis".Korean journal of anesthesiology · 2026Article
- Anemia and Iron Deficiency in Cardiac Surgery Patients: Prevalence, Implications, and Therapeutic Considerations.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile intravenous iron improves outcomes in anaemic surgical patients, the impact of iron deficiency (ID) and its treatment in non-anaemic patients remains unclear.
methodsIn this single-centre retrospective analysis, non-anaemic ID patients (age ≥ 18 years) undergoing major cardiac surgery at the University Hospital Frankfurt were included. Primary endpoints were red blood cell (RBC) transfusion rate and use of RBC units. Secondary endpoints were increase in haemoglobin levels and postoperative outcome (mortality, length of stay, mechanical ventilation, laboratory values). Patients were assigned to the following groups: No-Iron (no anaemia, ID, and no iron supplementation) and Iron (anaemia, ID, and iron supplementation).
resultsA total of 3605 patients were screened, of whom 2345 were non-anaemic. Six hundred ninety-eight non-anaemic ID patients were included in the analysis, of whom 90 received intravenous iron supplementation. The overall RBC transfusion rate (43.6% [95% CI: 39.6-47.6] versus 50.0% [95% CI: 39.9-60.1]) and number of transfused blood units (2.0 [IQR: 1.0; 4.0] versus 2.0 [IQR: 1.0; 4.0]) were similar between patients of the No-Iron and Iron groups. Hospital length of stay, mortality, and postoperative complications were similar in both groups. When applying stricter cutoff values to define ID (ferritin < 30 μg/l), a trend toward reduced transfusion rates was observed: total RBC transfusion rate was 50.0% (95% CI: 34.9-65.2) in the No-Iron group and 42.9% (95% CI: 26.8-60.5) in the Iron group. In the case of short-term (1 day prior to surgery) iron supplementation, RBC unit utilisation and postoperative outcomes were comparable between the two groups.
conclusionIn non-anaemic cardiac surgery patients, (short-term) preoperative intravenous iron supplementation showed no significant impact on RBC transfusion rate, haemoglobin levels, or postoperative outcomes. However, a stricter definition of ID revealed a trend toward reduced transfusion rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.